WLWulong Liu

Wulong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wulong Liu has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Weijing Liao

    Department of Neurological Rehabilitation, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

    1 shared publication
  • Xianglin Cheng

    Department of Rehabilitation Medicine, the First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China

    1 shared publication
  • Yao Zhang

    Department of Radiology, the First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China

    1 shared publication

Latest Publications

  • Open Access

    Effect of transcranial direct current stimulation combined with transcutaneous auricular vagus nerve stimulation on poststroke cognitive impairment: a study protocol for a randomised controlled trial

    by Wulong Liu, Xianglin Cheng, Yao Zhang, Weijing Liao

    Introduction Poststroke cognitive impairment is a common complication in stroke survivors, seriously affecting their quality of life. Therefore, it is crucial to improve cognitive function of patients who had a stroke. Transcranial direct current stimulation (tDCS) and transcutaneous auricular vagus nerve stimulation (taVNS) are non-invasive, safe treatments with great potential to improve cognitive function in poststroke patients. However, further improvements are needed in the effectiveness of a single non-invasive brain stimulation technique for cognitive rehabilitation. This study protocol aims to investigate the effect and neural mechanism of the combination of tDCS and taVNS on cognitive function in patients who had a stroke. Methods and analysis In this single-centre, prospective, parallel, randomised controlled trial, a total of 66 patients with poststroke cognitive impairment will be recruited and randomly assigned (1:1:1) to the tDCS group, the taVNS group and the combination of tDCS and taVNS group. Each group will receive 30 min of treatment daily, five times weekly for 3 weeks. Primary clinical outcome is the Montreal Cognitive Assessment. Secondary clinical outcomes include the Mini-Mental State Examination, Stroop Colour Word Test, Trail Marking Test, Symbol Digit Modalities Test and Modified Barthel Index. All clinical outcomes, functional MRI and diffusion tensor imaging will be measured at preintervention and postintervention. Ethics and dissemination The trial has been approved by the Ethics Committee of the First Affiliated Hospital of Yangtze University (approval no: KY202390). The results will be submitted for publication in peer-reviewed journals or at scientific conferences. Trial registration number ChiCTR2300076632.